CD4 and colorectal carcinoma: In another study, RSV therapy inhibited CRC growth in azoxymethane and DSS mice, boosting anti-inflammatory CD4+ FOXP3+ (Tregs) and CD4+ IL10+ cells, decreasing proinflammatory Th1 and Th17 cell growth, and modifying the gut flora (203).